cigna glp-1 coverage news today reaches new deal on Eli Lilly and Novo Nordisk weight loss drugs Your Weight-Loss Drugs Are Next

Those are the elements that you have to weigh

Recent data from the ATTAIN-MAINTAIN trial showed that patients transitioning to orforglipron after injectable GLP-1 therapy maintained their weight loss with minimal regain (approximately 0.9 kg after semaglutide transition), suggesting that oral maintenance strategies could minimize the lean mass depletion seen with prolonged high-dose injectable therapy

Gastric bypass surgery attenuates ethanol consumption in ethanol-preferring rats

Researchers are also actively exploring GLP-1s to help treat: Heart failure Osteoarthritis and joint pain Cognitive decline and brain health Weight Loss Effectiveness Across Different Groups New research from Johns Hopkins shows that GLP-1 medications work equally well for people of all ages, races, and starting weights

, ,

A BMP checks electrolytes and kidney markers